Linked Life Data

10656205

Source:http://linkedlifedata.com/resource/pubmed/id/10656205

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2000-5-2
pubmed:abstractText
Low bone density with an increased risk of vertebral fractures is a frequent complication in inflammatory bowel disease. Since the aetiology of osteopathia in these patients is different compared to postmenopausal or steroid-induced osteoporosis, no treatment strategy is established. Supplementation of calcium and vitamin D has been shown to prevent further bone loss, but no data are available showing the anabolic effect of sodium fluoride in Crohn's disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0954-691X
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
19-24
pubmed:dateRevised
2009-10-16
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Increase of bone mineral density with sodium fluoride in patients with Crohn's disease.
pubmed:affiliation
Department of Medicine I, University of Ulm, Germany.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial